An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing

This bill eliminates the state tax deduction for expenses related to direct-to-consumer advertising of prescription drugs and medical devices. It directly affects pharmaceutical companies and healthcare organizations that currently deduct marketing costs aimed at patients rather than doctors from their Massachusetts state income taxes. Under the new rules, businesses would no longer be able to reduce their taxable income by the amount they spend on media ads, coupons, or other promotional materials directed at the general public. The law specifies that for national or regional campaigns, only the portion of expenses attributable to Massachusetts residents would be disallowed from the deduction.